Yield Theory

Thomas Kean · JNJ

Thomas Kean's JNJ trades

Every Johnson & Johnson transaction Thomas Kean reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
7
Buys / sells
0 / 7
Disclosed range
$49K – $210K
Last filed
2026-09-12

JNJ transactions reported by Thomas Kean

7 of 7 rows
TypeOwner
Johnson & Johnson Common Stock
JNJ
SaleSelf$1,001 - $15,0002026-09-12
#20035431
Johnson & Johnson Common Stock
JNJ
SaleSelf$1,001 - $15,0002026-07-15
#20035003
Johnson & Johnson Common Stock
JNJ
SaleSelf$1,001 - $15,0002026-07-15
#20035003
Johnson & Johnson Common Stock
JNJ
SaleSelf$1,001 - $15,0002026-04-13
#20034327
Johnson & Johnson Common Stock
JNJ
SaleSelf$15,001 - $50,0002026-02-19
#20034025
Johnson & Johnson Common Stock
JNJ
SaleSelf$15,001 - $50,0002025-12-19
#20033659
Johnson & Johnson Common Stock
JNJ
SaleSelf$15,001 - $50,0002025-08-20
#20030946

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Thomas Kean and JNJ — questions

Did Thomas Kean buy or sell JNJ?

House Clerk filings for 2025 and 2026 show 0 purchases and 7 sales of Johnson & Johnson (JNJ) reported by Thomas Kean, between 2025-07-31 and 2026-08-27. Reported owner: Self.

How much JNJ did Thomas Kean trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $49K – $210K across 7 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last JNJ filing by Thomas Kean?

The most recent periodic transaction report containing a JNJ row was filed on 2026-09-12. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Johnson & Johnson. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Thomas Kean JNJ disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included